MeiraGTx Holdings plc
General ticker "MGTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $528.0M (TTM average)
MeiraGTx Holdings plc follows the US Stock Market performance with the rate: 52.4%.
Estimated limits based on current volatility of 3.7%: low 7.86$, high 8.47$
Factors to consider:
- Total employees count: 381 (-10.4%) as of 2024
- Top business risk factors: High R&D costs, Regulatory and compliance, Market volatility, Supply chain disruptions, Cybersecurity threats
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [4.38$, 9.57$]
- 2025-12-31 to 2026-12-31 estimated range: [3.94$, 8.83$]
Financial Metrics affecting the MGTX estimates:
- Negative: with PPE of -2.4 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -24.76 <= 0.33
- Positive: 18.93 < Shareholder equity ratio, % of 25.14 <= 41.86
- Positive: Investing cash flow per share per price, % of 5.56 > -0.66
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Net income
Short-term MGTX quotes
Long-term MGTX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $15.92MM | $14.02MM | $33.28MM |
| Operating Expenses | $132.28MM | $151.08MM | $197.49MM |
| Operating Income | $-116.36MM | $-137.06MM | $-164.21MM |
| Non-Operating Income | $-13.26MM | $53.03MM | $16.42MM |
| Interest Expense | $4.95MM | $13.24MM | $13.27MM |
| R&D Expense | $85.72MM | $103.78MM | $119.48MM |
| Income(Loss) | $-129.62MM | $-84.03MM | $-147.79MM |
| Profit(Loss)* | $-129.62MM | $-84.03MM | $-147.79MM |
| Stockholders Equity | $117.74MM | $138.18MM | $67.83MM |
| Inventory | $0.00MM | $0.00MM | $0.39MM |
| Assets | $318.24MM | $326.74MM | $269.75MM |
| Operating Cash Flow | $-73.10MM | $-105.36MM | $-104.50MM |
| Capital expenditure | $44.96MM | $20.17MM | $4.96MM |
| Investing Cash Flow | $-44.96MM | $34.03MM | $23.48MM |
| Financing Cash Flow | $95.20MM | $84.02MM | $54.53MM |
| Earnings Per Share** | $-2.87 | $-1.49 | $-2.12 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.